• Laboratory scientists develop new cancer-killing drug
    The discovery has been described as a "breakthrough"

News & Views

Laboratory scientists develop new cancer-killing drug

May 11 2010

Laboratory scientists have unveiled a new non-invasive and non-toxic method of treating lymphoma cells in cancer patients.

Described as a "breakthrough" by the Samuel Waxman Cancer Research Foundation, the treatment is a drug that targets an oncogene known as BCL6.

Associate professor of medicine at Weill Cornell Medical College in New York City Dr Alexander MacKerell said BCL6 is a protein that controls "thousands of other genes".

"Because of that, it has a very profound impact on cells and is required for lymphoma cells to survive and multiply," he explained.

According to the expert, current chemotherapy methods for large B cell lymphomas cure 60 per cent of patients, but it is hoped a larger number can be saved with the new medication.

It is possible that the drug may eventually negate the need for toxic treatments completely, he added.

Last month, laboratory scientists at Fox Chase Cancer Center revealed they may have found an innovative way to screen early for ovarian tumours.

Digital Edition

LMUK 49.7 Nov 2024

November 2024

Articles - They’re burning the labs... Spotlight Features - Incubators, Freezers & Cooling Equipment - Pumps, Valves & Liquid Handling - Clinical, Medical & Diagnostic Products News...

View all digital editions

Events

MEDICA 2024

Nov 11 2024 Dusseldorf, Germany

FILTECH

Nov 12 2024 Cologne, Germany

Intech

Nov 12 2024 Tel Aviv, Israel

analytica China

Nov 18 2024 Shanghai, China

Pharma Asia

Nov 20 2024 Karachi, Pakistan

View all events